PROCEPT BioRobotics is a medical device company that develops a novel minimally invasive technology to surgically treat prostate disease. The first product developed is the AquaBeam, an intelligent image-guided robotic system delivering Aquablation, a personalized waterjet tissue resection modality. Under real-time image-based ultrasonic guidance, AquaBeam enables surgical planning and mapping, and allows for a controlled resection of the prostate with a high-velocity saline stream. The combination of surgical mapping and controlled resection of the prostate is designed to offer predictable and reproducible outcomes which will enable quicker adoption and scaling of the technology. The company is privately held and headquartered in Redwood Shores, California. The AquaBeam is not currently available for sale in the United States.

Key Contact